Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genome Research Limited (GRL) is the charitable company that operates the Wellcome Sanger Institute, one of the world's leading centers for genomic research. The organization focuses on understanding the role of genetics in health and disease by conducting large-scale sequencing projects and developing advanced bioinformatics tools. GRL plays a pivotal role in global initiatives such as the Human Genome Project and the Cancer Genome Project, providing open-access data to the scientific community. Beyond basic research, the group fosters innovation through the Wellcome Genome Campus, supporting the translation of genomic discoveries into clinical diagnostics and therapeutic interventions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genome Research Group.